In addition to developing outstanding clinicians, Hematology/Oncology fellows at Mayo Clinic are extremely productive academically. Research support and mentorship begins on day one of the fellowship. With teaching and mentorship from world-renowned experts in every tumor and disease group, you are given the support and guidance to excel both clinically and in research.
Basic and translational research
We offer a wide range of basic and translational research opportunities in many areas of hematology and oncology, including:
- Gene and viral therapies
- Cell-based therapies
- Experimental therapeutics (phases I and II)
- Genomics and proteomics
- Artificial intelligence in medicine
Mayo Clinic conducts hundreds of clinical trials for patients with both rare and common cancers, including a robust Phase I program and a heavily translational Phase II trials. Along with Phase III trial participation, there is frequent involvement in the conception and conduct of these trials at a national leadership level by Mayo staff physicians, as well as development and performance of translational studies within these trials. Mayo Clinic serves as the lead statistical center for the Alliance for Clinical Trials in Oncology cooperative group.
In addition, many basic and translational science investigators are based in the Mayo Clinic Cancer Center, the Department of Oncology, the Division of Hematology, and the Transplant Center. Team science with an eye to translation is an emphasis at Mayo Clinic, as evidenced by the multiple disease-specific National Cancer Institute-funded Specialized Programs of Research Excellence (SPORE) grants held by Mayo Clinic.
Mayo Clinic's Center for Individualized Medicine offers infrastructure and funding for innovative research ideas. The Robert D. and Patricia E. Kern Center for Science of Health Care Delivery is focused on testing theories, models and methods to improve patient care. Other research strengths at Mayo include epidemiology, cancer control, and health care delivery.